Belle Mead, NJ, United States of America

Adam W Sledeski

USPTO Granted Patents = 9 


 

Average Co-Inventor Count = 5.4

ph-index = 4

Forward Citations = 55(Granted Patents)


Location History:

  • Collegeville, PA (US) (2000 - 2004)
  • Bridgewater, NJ (US) (2012)
  • Belle Mead, NJ (US) (2013 - 2014)

Company Filing History:


Years Active: 2000-2014

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Exploring the Innovations of Adam W Sledeski

Introduction:

In the world of patents and inventions, it is essential to recognize brilliant minds that contribute to advancements in various industries. Adam W Sledeski, hailing from Belle Mead, NJ (US), is one such individual, with a notable portfolio of patents and a career in renowned pharmaceutical companies. This article delves into his latest patents, career highlights, and collaborations, shedding light on his valuable contributions to the field of innovation.

Latest Patents:

Adam W Sledeski has nine patents to his name, showcasing his expertise and dedication to scientific advancements. His recent patents include two significant inventions:

1. Synthesis of (4-fluoro-3-piperidin-4-yl-benzyl)-carbamic acid tert-butyl ester and intermediates thereof:

This patent introduces an improved method for synthesizing (4-fluoro-3-piperidin-4-yl-benzyl)-carbamic acid tert-butyl ester, referred to as compound I. The process involves a three-step synthesis, including the formation of compound 11, reaction under Suzuki coupling conditions, and selective hydrogenation. Additionally, the patent covers the intermediates, compound 11 and compound 13.

2. Method and intermediates for the preparation of 2,2,2-trifluoro-N-(4-fluoro-3-pyridin-4-yl-benzyl)-acetamide hydrochloride:

This patent outlines a method for preparing 2,2,2-trifluoro-N-(4-fluoro-3-pyridin-4-yl-benzyl)-acetamide hydrochloride, along with the corresponding reaction intermediates. This compound holds potential applications in the field of pharmaceuticals.

Career Highlights:

Adam W Sledeski's expertise in the pharmaceutical industry is evident through his associations with renowned companies such as Aventis Pharmaceuticals Products Inc. and Aventis Pharmaceuticals Inc. Though specific details regarding his contributions within these companies are not available, his involvement demonstrates a long-standing commitment to fostering innovation and progress within the pharmaceutical realm.

Collaborations:

Collaboration plays a vital role in innovation, often leading to groundbreaking inventions. Adam W Sledeski has had the opportunity to work alongside prominent individuals in his field, including James J Mencel and Matthew R Powers. Collaborative efforts allow for the exchange of ideas, expertise, and knowledge, bolstering the potential for transformative discoveries.

Conclusion:

Adam W Sledeski's dedication to advancements in pharmaceuticals is underscored by his impressive patent portfolio and collaborations with esteemed professionals. Through his inventions, such as the improved methods and synthesis pathways outlined in his recent patents, Sledeski showcases his expertise and commitment to scientific progress. His contributions make a lasting impact on the field of innovations and patents, shaping the future of pharmaceutical research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…